Research Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
Endocrine. 2022 Jan;75(1):1-9. doi: 10.1007/s12020-021-02923-7. Epub 2021 Oct 30.
Type 2 diabetes (T2D) increases the risk of coronavirus disease (COVID-19). This study investigates the association between glucose control of COVID-19 patients with T2D in first 7 days after hospital admission and prognosis. A total of 252 infected inpatients with T2D in China were included. Well-controlled blood glucose was defined as stable fasting blood glucose (FBG) levels in the range of 3.9-7.8 mmol/L during first 7 days using indicators of average (FBG), maximum (FBG) or first-time (FBG) FBG levels. The primary endpoint was admission to intensive care unit or death. Hazard ratio (HR) of poorly controlled glucose level group compared with well-controlled group were 4.96 (P = 0.021) for FBG and 5.55 (P = 0.014) for FBG. Well-controlled blood glucose levels in first 7 days could improve the prognosis of COVID-19 inpatients with diabetes.
2 型糖尿病(T2D)会增加患冠状病毒病(COVID-19)的风险。本研究旨在探讨 COVID-19 患者入院后 7 天内血糖控制情况与预后之间的关系。该研究共纳入了 252 例中国住院 T2D 感染患者。血糖控制良好定义为入院后 7 天内空腹血糖(FBG)水平稳定,平均(FBG)、最大(FBG)或首次(FBG)FBG 水平在 3.9-7.8mmol/L 范围内。主要终点为入住重症监护病房或死亡。与血糖控制良好组相比,血糖控制不佳组的 FBG 风险比(HR)为 4.96(P=0.021),FBG 为 5.55(P=0.014)。入院后 7 天内血糖控制良好可改善 COVID-19 糖尿病住院患者的预后。